Comparative molecular dynamics simulation of Hepatitis C Virus NS3/4A protease (Genotypes 1b, 3a and 4b) predicts conformational instability of the catalytic triad in drug resistant strains.
The protease domain of the Hepatitis C Virus (HCV) nonstructural protein 3 (NS3) has been targeted for inhibition by several direct-acting antiviral drugs. This approach has had marked success to treat infections caused by HCV genotype 1 predominant in the USA, Europe, and Japan. However, genotypes...
Guardado en:
Autores principales: | Mitchell Kramer, Daniel Halleran, Moazur Rahman, Mazhar Iqbal, Muhammad Ikram Anwar, Salwa Sabet, Edward Ackad, Mohammad S Yousef |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9f7427732cf417797fc96dbb2d4866c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structure of the NS2B-NS3 protease from Zika virus after self-cleavage
por: Wint Wint Phoo, et al.
Publicado: (2016) -
Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection
por: Courtney E. Comar, et al.
Publicado: (2019) -
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
por: Ashley N. Matthew, et al.
Publicado: (2020) -
Dabrafenib, idelalisib and nintedanib act as significant allosteric modulator for dengue NS3 protease.
por: R V Sriram Uday, et al.
Publicado: (2021) -
Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain.
por: Assaf Shapira, et al.
Publicado: (2011)